User Support Reference Group

Page tree

Versions Compared

Old Version 2

changes.mady.by.user Shane Byrnes

Saved on

compared with

New Version Current

changes.mady.by.user Shane Byrnes

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Info
titleMeeting Details

Date & Time: 3rd July 2025 11am UTC


Info
titleObjectives
  • Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.

Attendees:

Shane Byrnes Alejandro Lopez Osornio Yongsheng Gao Monica Harry Jerry O'Sullivan Venkata Aditya Parnandi Betania Arispe Claudie Sombie Colin Macfarlane Elisabeth Serrot Emilie Nguyen Emma Melhuish Francois Lavoie Ger Gahan Guillermo Reynoso Hanne Johansen Herman Muys Jaya Sonavane Jessica MacDougall Julia Xu Julie Boutin Julie M. James Julien Montreuil Krista Lilly Laila Barrouhou Linda Bird Maria Gomez Mari­a Yunes Marine Rodrigeuz Michael Keary Nicholas McGraw Nicola Ingram Noelle Horan Marta Pavón Garrido Patricia Houghton Patrick McLaughlin Paul Wright Robert Wynne Rossana Occhiuzzi Stuart Abbott Tara Kelly Yolaine Forget Ana Paredes Theresa Barry 



Info
titleZoom Link

Link: https://snomed.zoom.us/my/deusg?pwd=AypAgYBV0fzn7G0ZAaXCqzMz1gP5LE.1


Info
titleMeeting Recording

Link: Recording Link

Passcode: 9AE.en%5


Discussion items

Item

Description

Mins

Owner

Notes & Actions

1Opening52

Shane Byrnes 
Alejandro Lopez Osornio

Welcome & Notification of Recording

2Substances Co-ordination10

Krista Lilly Alejandro Lopez Osornio 

Updates on Substances Co-Ordination:

  • Step 1: Substances in multiple extensions
  • Step 2: Substances in one extension
    • Country self-review/first pass
    • Then, SI will review in scope
3Hydration - Demonstrate Examples35

Yongsheng Gao 

Guillermo Reynoso Linda Bird 

Updates on development work in relation to hydration substances.

4Vaccine Substances52Shane Byrnes 

For Information: WHO recommended flu vaccine antigen substances for 2025/2026 season (Northern Hemisphere) are now available in International Release

5AOB5All
  • 1366440009 Antigen of Influenza B virus B/Austria/1359417/2021 (B/Victoria lineage)-like virus strain (substance)
  • 1366438004 Antigen of Influenza A virus A/Croatia/10136RV/2023 (H3N2)-like virus strain (substance)
  • 1366437009 Antigen of Influenza A virus A/Victoria/4897/2022 (H1N1)pdm09-like virus strain (substance)
  • 1366436000 Antigen of Influenza A virus A/District of Columbia/27/2023 (H3N2)-like virus strain (substance)
  • 1366435001 Antigen of Influenza A virus A/Wisconsin/67/2022 (H1N1)pdm09-like virus strain (substance)
  • 1366374009 Antigen of Influenza B virus B/Phuket/3073/2013 (B/Yamagata lineage)-like virus strain (substance)
5Has Container Type5

Linda Bird 

Feedback on Canada plans to use the |Physical object| hierarchy (specifically < 398124009 |Drug container (physical object)|) for the range of the |Has container type| relationship

6'Drug Therapy' v 'Administration of drug'5Nicola Ingram 

Group feedback sought on 'Drug Therapy' versus 'Administration of Drug' on Discussion Forum

7AOB
All
  1. National Extension Model Guide: User query on FSNs and PTs for combination 'Packaged Clinical Drug'. How are countries approaching this?
86Topic Backlog

  • Hydration Subsumption
  • Less Granular Clinical Drug
  • Elemental Substances (Matt, AUS)
  • Substances Co-ordination
    • Step 1: Substances in multiple extensions
    • Step 2: Substances in one extension
    • Step 3: Ongoing Substance Co-ordination (capturing at regulator level)
  • Medication Stopped v Medication Discontinued (Karen, SI)
  • Medicinal Product promotion co-ordination (Oslo group discussion as linked to substances work + ES)
  • Value range of a |Has container type| attribute (Linda, CA)
  • Top level children of 373873005 |Pharmaceutical / biologic product| hierarchy - are members using/how are members using? (AUS) 
  • Routes of Administration - Implementation Considerations (Mia, NZ)
  • Group Input on Patch Strength Representation
  • Dose Form Intended Site v Route of Administration (BEL)
  • Drug extension MRCM attributes (CA, AUS)


Attachments

...